Rapid Nutrition Past Earnings Performance

Past criteria checks 0/6

Rapid Nutrition's earnings have been declining at an average annual rate of -33.6%, while the Personal Products industry saw earnings growing at 2.9% annually. Revenues have been declining at an average rate of 11.7% per year.

Key information

-33.6%

Earnings growth rate

1.6%

EPS growth rate

Personal Products Industry Growth16.1%
Revenue growth rate-11.7%
Return on equity-268.6%
Net Margin-241.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Calculating The Intrinsic Value Of Rapid Nutrition PLC (EPA:ALRPD)

Feb 16
Calculating The Intrinsic Value Of Rapid Nutrition PLC (EPA:ALRPD)

Revenue & Expenses Breakdown

How Rapid Nutrition makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALRPD Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241-330
31 Mar 241-330
31 Dec 232-220
30 Sep 232-770
30 Jun 233-12110
31 Mar 233-11110
31 Dec 223-10110
30 Sep 222-560
30 Jun 222120
31 Mar 222120
31 Dec 213020
30 Jun 212-420
31 Mar 212-420
31 Dec 202-420
31 Dec 194110
30 Sep 194110
30 Jun 193110
31 Mar 192110
31 Dec 182210
30 Sep 183210
30 Jun 184220
31 Mar 184120
31 Dec 174020
30 Sep 174120
30 Jun 173120
31 Mar 173110
31 Dec 163210
30 Sep 163210
30 Jun 163210
31 Mar 164130
31 Dec 155150
30 Sep 156150
30 Jun 156140
31 Mar 154030
30 Jun 142210
31 Mar 141300

Quality Earnings: ALRPD is currently unprofitable.

Growing Profit Margin: ALRPD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALRPD is unprofitable, and losses have increased over the past 5 years at a rate of 33.6% per year.

Accelerating Growth: Unable to compare ALRPD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALRPD is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.8%).


Return on Equity

High ROE: ALRPD has a negative Return on Equity (-268.63%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:54
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rapid Nutrition PLC is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Longdley ZephirinZephirin Group, Inc.